Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-041806
Filing Date
2021-06-17
Accepted
2021-06-17 21:21:07
Documents
1
Period of Report
2021-06-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7426
  Complete submission text file 0001209191-21-041806.txt   10056
Mailing Address 3340 HILLVIEW AVENUE PALO ALTO CA 94304
Business Address 3340 HILLVIEW AVENUE PALO ALTO CA 94304 650 475 3734
Venrock Management VII, LLC (Reporting) CIK: 0001614686 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40499 | Film No.: 211026896

Mailing Address 3340 HILLVIEW AVENUE PALO ALTO CA 94304
Business Address 3340 HILLVIEW AVENUE PALO ALTO CA 94304 650 475 3734
Venrock Partners VII, L.P. (Reporting) CIK: 0001614765 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40499 | Film No.: 211026897

Mailing Address 3340 HILLVIEW AVENUE PALO ALTO CA 94304
Business Address 3340 HILLVIEW AVENUE PALO ALTO CA 94304 650 475 3734
Venrock Associates VII, L.P. (Reporting) CIK: 0001614766 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40499 | Film No.: 211026898

Mailing Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421 857-285-4140
Cyteir Therapeutics, Inc. (Issuer) CIK: 0001662244 (see all company filings)

EIN.: 455429901 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations